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The most plausible theory of the aetiology of endemic nephropathy links it with exposure to nephrotoxic 
mycotoxin ochratoxin A (OTA). In this study, the concentration of OTA and sphinganine/sphingosine 
(Sa/So) ratio, the biomarker of another nephrotoxic mycotoxin fumonisin B
1
 exposure, were analysed in 45 
human urine samples collected in the endemic village of Kaniža in Croatia and in 18 samples from control 
village. Samples were collected twice from the same persons in 2000 and 2005. In both years the frequency 
of OTA-positive samples was higher in Kaniža (43 % and 18 %, respectively) than in the control village 
(28 % and 6 %, respectively). OTA concentrations in samples collected in Kaniža were higher in 2000 
than in 2005 (p<0.005). Although in both years Sa/So ratio was higher in Kaniža, the difference from the 
control group was not statistically signifi cant. No control sample contained OTA and had the Sa/So ratio 
>1 at the same time, while in Kaniža four such samples were collected in 2000 and one in 2005.
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Endemic nephropathy (EN) is a fatal human kidney 
disease that occurs in 14 villages in the eastern part 
of the Croatian Brodsko-posavska county. In the 
1970s, the aetiology of the disease was believed to 
be related to exposure to mycotoxin ochratoxin A 
(OTA) (1). High incidence of otherwise rare urothelial 
tumours observed later in the same endemic region 
was also associated with this toxin (2, 3). Studies 
on laboratory and domestic animals have shown 
that OTA is nephrotoxic, carcinogenic, genotoxic, 
and immunotoxic (4). The International Agency for 
Research on Cancer (IARC) has classifi ed OTA as 
Group 2B carcinogens (possible human carcinogen) 
(5). OTA was found in various commodities from 
endemic villages (6), and its concentration was 
much higher in maize collected in the endemic than 
in control regions in the 1997 crop (7). The same 
difference was observed by Puntarić et al. (8) for wheat 
and maize samples collected in 1999. Although OTA 
was more frequent in the plasma of the residents of 
endemic villages, it was also found in the plasma of the 
residents of control villages (9). Low concentrations of 
OTA are frequent in the healthy population of Croatia 
and other countries where EN is not known (10).
Some earlier studies on maize contamination with 
mycotoxins in the endemic region and the whole 
of Croatia revealed a high percentage of samples 
contaminated with fumonisins and to a lesser extent 
with OTA (7, 11). The most frequent fumonisin in 
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). In some regions of 
Africa and China unusually frequent oesophageal 
cancer and primary liver cancer in humans was 
associated with high exposure to FB
1
. IARC classifi ed 
FB
1
 in the same group of carcinogens as OTA (Group 
2B) (12). Animal studies have shown that FB
1
 is poorly 
absorbed and rapidly distributed and eliminated. 
This makes FB
1
 measurement in biological materials 
useless for evaluation of exposure to this mycotoxin. 
However, it is established that FB
1 
toxicity is the 
consequence of the inhibition of ceramide synthase, 
a key enzyme in the biosynthesis of sphigolipids. 
Animal studies have shown that an elevated ratio of 
sphingolipids sphinganine and sphingosine (Sa/So) is 
a reliable biomarker of exposure to fumonisins. This 
marker had already been evaluated in the serum and 
urine of subjects living in the EN region (13), and 
the study showed higher Sa and So concentrations, 
and higher Sa/So ratio in residents of the endemic 
region.
The geographically limited occurrence of EN and 
particular urothelial tumours suggest that some other 
natural contaminant could add to OTA toxicity and 
contribute to the development of EN. Since earlier 
exposure data for the residents of the endemic villages 
are separate for OTA and fumonisins (Sa/So ratio), 
the aim of this study was to see whether exposure to 
these two mycotoxins was in fact combined. The same 
subjects were tested for these two mycotoxins in 2000 
and 2005 to accommodate for high variability of grain 
contamination from year to year.
MATERIALS AND METHODS
Chemicals






o-phthaldialdehyde (OPA), and 2-mercaptoethanol 
were purchased from Sigma (St. Louis, MO, USA). 
Water for HPLC mobile phase and silica gel Si-60 (15 
µm to 40 µm) were obtained from Merck (Darmstadt, 
Germany). Methanol, acetic acid, hydrochloric acid, 
chloroform, sodium sulphate anhydrous crystal, 
and formic acid were supplied by Kemika (Zagreb, 
Croatia). All chemicals were of pro-analysis grade. 
Water and methanol used for HPLC mobile phase 
were of HPLC grade.
Urine samples
For OTA and sphingolipid analysis, spot human 
urine samples were collected from 63 subjects in the 
spring of 2000 and 2005, and kept frozen at -80 °C until 
analysis. Forty-fi ve samples were from the endemic 
village of Kaniža and 18 from a control village where 
EN is not known. Urine was sampled according to the 
Croatian law, with the previous approval of the Ethics 
Committee of the Institute for Medical Research and 
Occupational Health in Zagreb.
HPLC system
The high-performance liquid chromatograph 
used in the experiment consisted of a gradient pump 
(INERT 9012, Varian, Walnut-Creek, CA, USA), 
manual injector (Rheodyne 7125, Cotati, CA, USA) 
with a 50 µL loop, and a fl uorescent detector (9075, 
Varian, Walnut-Creek, CA, USA). The guard column 
and analytical column were LiChrospher RP-18 
(Merck, Darmstadt, Germany) with 5 µm particles 
and their size was 4 mm x 4 mm and 125 mm x 4 mm, 
respectively. Chromatographic data were collected and 
processed using Star Chromatography Workstation 
software (Ver. 5.0, Varian, Walnut-Creek, CA, USA). 
The analysis was performed at room temperature.
Determination of OTA
To determine OTA concentrations in the urine we 
adopted the method of Pascale and Visconti (14). This 
method uses immunoaffi nity columns (OchraTestTM, 
Vicam, Watertown, MA, USA) for sample cleanup 
procedure. Urine samples (10.0 mL) were diluted with 
5 % NaHCO
3
 (10.0 mL), mixed, and fi ltered through 
Whatman No.1 fi lter paper. Ten mL of fi ltered sample 
were transferred to OchraTestTM immunoaffinity 
columns. Immunoaffinity columns were washed 
twice with distilled water (5.0 mL), and OTA was 
eluted with 2 mL methanol. The eluted extract was 
evaporated under a stream of nitrogen in a water 
bath at 60 °C. The residues were kept at +4 °C until 
analysis. Just before HPLC analysis, the residues were 
dissolved in 300 µL of the mobile phase.
For OTA analysis, the mobile phase consisted of 
methanol, water, and acetic acid (70:30:2), and the 
fl ow-rate was 0.5 mL min-1. The excitation wavelength 
of the fl uorescence detector was set at 336 nm, and 
the emission wavelength was 464 nm. Validation of 
the method showed linear standard curve (r2=0.998). 
OTA detection limit of the method was 0.005 ng mL-1 
and reproducibility (day to day precision), expressed 
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as relative standard deviation (RSD), was 3.5 %. The 
presence of OTA in some OTA-positive samples was 
confi rmed by adding OTA standard to the sample.
Determination of sphingolipids
Free So and Sa concentrations in the urine samples 
were determined using the method of Solfrizzo et 
al. (15). Urine (2.0 mL) was diluted with methanol 
(1.9 mL), alkalinised with 1.2 mL NH
4
OH (0.35 mol 
L-1), and extracted with chloroform (4.0 mL). After 
centrifugation, the chloroform extract was cleaned 
up through a silica gel mini-column consisting of 
5.0 g of sodium sulphate anhydrous crystal packed 
on top of 0.2 g silica gel 60. The mini-column was 
conditioned with chloroform and then loaded with the 
sample. So and Sa were eluted from the mini-column 




OH (50:50:2). The 
collected eluate was evaporated to dryness in a water 
bath under a stream of nitrogen at 60 °C. Before 
injection, the sample was redissolved in 250 µL of 
methanol, and derivatised in reaction with 50 µL of 
o-phthaldialdehyde (OPA).
The mobile phase consisted of methanol and water 
(90:10). The fl ow rate was 1.0 mL min-1. Wavelengths 
of the detector were set at λ
em
334 nm and λ
ex
440 nm. 
Validation of the method showed linear standard 
curves for So and Sa (with r2=0.997 and r2=0.996, 
respectively). The detection limit for sphingolipids 
was 0.1 ng mL-1 and RSD below 10 %.
Statistics
Differences in the means of two independent 
samples between the groups were evaluated with the 
Student’s t-test using Statistica 5.0. Probability values 
of p<0.05 were considered statistically signifi cant.
RESULTS
Tables 1 and 2 show urine OTA concentrations 
and Sa/So ratio measured in samples collected from 
45 residents of the endemic village of Kaniža and 18 
control subjects in 2000 and 2005. In both years the 
mean OTA concentration in positive samples was 
higher in Kaniža than in control samples. Mean OTA 
concentration in all samples collected in Kaniža in 
2000 was higher than in 2005 (p<0.005).
In both years the frequency of OTA-positive 
samples was also higher in Kaniža residents than 
controls. In addition, it was higher in 2000 than in 
2005 in both groups of subjects.
Mean Sa/So ratio was higher in the urine collected 
from Kaniža residents than from controls in both years 
(Table 2). No control urine sample had the Sa/So 
ratio >1.0. The number of samples from Kaniža with 
Sa/So ratio >1.0 was higher in 2000 than in 2005. 
Four samples collected from Kaniža in 2000 and one 
in 2005 contained both detectable amounts of OTA 
and Sa/So ratio >1.
DISCUSSION
Mycotoxins are still the most plausible cause 
of EN development. EN’s geographically limited 
occurrence in Croatia and other countries suggests 
that its aetiology should involve a local natural toxin. 
The most common suspect is OTA, which was found 
more frequently in the plasma of endemic region 
residents than in controls (9). As OTA is excreted via 
urine, positive urine fi nding is used to confi rm human 
exposure to this mycotoxin (14, 16, 17).
In our study, OTA-positive samples were found in 
both subject groups and in both years of sampling. This 
result is not surprising because we had already found 
OTA in the plasma of healthy Croatian population 
who did not live in the endemic area (10). However, 
the frequency of positive samples was higher in the 
residents of the endemic village of Kaniža than in the 
control village, which corroborates the study by Radić 
et al. (9). This could be the consequence of higher 
OTA contamination of cereals in the endemic than in 
other areas (7, 8).
It is interesting to note that the higher mean 
concentration of OTA and higher percentage of OTA-
positive urine samples was found in 2000 than in 2005 
regardless of the sampling location. The urine samples 
were collected in the spring, when the subjects still 
consumed last year’s crop. According to the data of the 
Meteorological and Hydrological Service of Croatia, 
the years preceding urine sampling were climatically 
very different. In 1999, the temperature and rainfall 
in the EN area signifi cantly exceeded the long term 
average, while in 2004, both parameters were only 
slightly above the normal (18). In the endemic area 
of Croatia, significant year-to-year variability of 
OTA concentration has already been observed for 
maize (7).
In our study of maize collected in 14 counties of 
Croatia, FB
1
 concentration was above the detection 
limit in all samples (11). A similar very high frequency 
of FB
1
-positive samples was found in maize collected 
Domijan A-M, et al. URINE OTA AND SA/SO RATIO AS BIOMARKERS IN ENDEMIC NEPHROPATHY
Arh Hig Rada Toksikol 2009;60:387-393
390
both from the endemic and non-endemic areas (7). In 
the only Croatian study of urine Sa/So ratio performed 
by now, this ratio was signifi cantly higher in persons 
with suspected EN and in healthy subjects from 
the endemic area than in controls, regardless of the 
sex (13). In our study, mean urine Sa/So ratio was 
also higher in Kaniža residents than in controls, but 
due to the high variability of data, this difference is 
not statistically signifi cant (Table 2). Although the 
endemic area is not known for high consumption 
of maize, mean Sa/So ratio in the urine collected in 
2000 and 2005 in Kaniža was similar or higher (1.79 
and 1.45, respectively) than in the urine of persons 
living in the areas of North Argentina and South 
Brazil known for high consumption of maize (0.69 
and 1.57, respectively) (19). Control values for Sa/So 
in our study in 2000 and 2005 were 0.19 and 0.33, 
respectively, which is in accordance with the Sa/So 
ratios from earlier studies ranging from 0.12 to 0.43 
(13, 19-21).
It is known that FB
1
 signifi cantly increases Sa and 
to a lesser extent So concentration in experimental 
animals. This discrepancy refl ects in changed Sa/So 
ratio. Studies of humans consuming home-grown 
maize contaminated with fumonisins showed no 
increase in the Sa/So ratio (19). It seems that change 
in the Sa/So ratio is not sensitive enough to be a 
biomarker of fumonisin exposure in humans, probably 
because humans are exposed to a much lower level of 
fumonisins than experimental animals. The arbitrary 
Sa/So ratio cut off of above 1.0 shows that Sa is 
higher than So, which in turn suggests exposure to 
fumonisins. When we set the cut off for Sa/So ratio to 
1.0 (see 19), we found that all samples >1.0 originated 
from Kaniža (Table 2).
Although the co-occurrence of OTA and FB
1
 in 
maize seems to be quite frequent in Croatia (7, 11), 
only fi ve samples in our study, all of them collected 
in Kaniža, indicated the exposure to both mycotoxins. 
This is probably because these mycotoxins are 
Table 1 Mean OTA concentrations in urine samples and the frequency of positive samples in 2000 and 2005
Year Samples N n
All samples Positive samples Frequency 
of positive 
samples /%
Mass concentration of OTA / ng mL-1
Mean ± SD Range
2000
Controls 18 5 0.003±0.005 0.01±0.006 0.005 to 0.02 28
Kaniža 45 19 0.007±0.014 0.017±0.018 0.005 to 0.086 43
2005
Controls 18 1 0.005±0.024 0.01 0.01 6
Kaniža 45 8 0.001±0.003** 0.007±0.003 0.005 to 0.015 18
N – number of samples
n – number of positive samples
** different from concentration in Kaniža in 2000 (p<0.005)
Table 2 Mean sphingosine (Sa) and sphinganine (So) concentrations, Sa/So ratios, and the frequency of samples with Sa/So 




Sa/So < 1 Sa/So > 1










Controls 18 3.72±2.83 0.79±0.75 0.19±0.09 18 100 - -
Kaniža 45 2.54±2.95 2.47±2.90 1.79±1.98 33 73 12 27
2005
Controls 18 5.84±8.05 1.78±2.86 0.33±0.27 18 100 - -
Kaniža 45 0.93±0.46 2.38±9.34 1.45±4.44 43 96 2 4
N – number of samples
n – number of positive samples
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produced by different moulds (mostly Penicillium spp. 
and Fusarium spp., respectively). Human exposure to 
these two mycotoxins is particularly interesting not 
only because of additive and even synergistic effect 
on cultured cells (22, 23) but also because of the 
synergistic increase in DNA lesions seen in the kidney 
of experimental animals treated with both mycotoxins 
(24). Despite the well-known nephrotoxicity and 
carcinogenicity of OTA and FB
1
 in vitro and in animal 
studies, nothing is known about their effect in humans. 
This is the fi rst report on combined human exposure to 
these two mycotoxins. Our results have confi rmed that 
human exposure to OTA and FB
1
 varies from year to 
year. Higher frequency of OTA-positive samples and 
the higher number of samples with Sa/So ratio >1.0 
in the endemic than in the control village call for a 
continued study of this issue.
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Sažetak
OKRATOKSIN A I OMJER SFINGANINA I SFINGOZINA U URINU STANOVNIKA S PODRUČJA 
ENDEMSKE NEFROPATIJE U HRVATSKOJ
Najprihvatljivija teorija o etiologiji endemske nefropatije povezuje njezin nastanak s izloženošću 
nefrotoksičnim mikotoksinima. Dok se izloženost mikotoksinu okratoksinu A (OTA) može dokazati 





) u organizmu to onemogućava. Na pokusnim je životinjama nađeno da je porast omjera koncentracija 
sfi ngolipida sfi nganina i sfi ngozina (Sa/So) biološki pokazatelj izloženosti tom mikotoksinu. U ovom 
istraživanju mjerena je koncentracija OTA i omjer koncentracija Sa/So u urinu 45 stanovnika u endemskom 
selu Kaniža i 18 stanovnika u kontrolnom selu. Uzorci urina skupljeni su od istih osoba 2000. i 2005. 
godine. U obje godine učestalost uzoraka koji su sadržavali OTA bila je veća u Kaniži (43 % i 18 %) 
negoli u kontrolnom selu (28 % i 6 %). Koncentracija OTA također je bila viša u urinima skupljenim u 
Kaniži negoli u kontrolnom selu. Koncentracija OTA u uzorcima skupljenim u Kaniži 2000. bila je viša 
nego u uzorcima iz 2005. (p<0.005). Iako je u urinima iz obje godine omjer koncentracija Sa/So bio viši u 
Kaniži negoli u kontrolnom selu, razlika nije bila statistički značajna. Nije nađen nijedan uzorak skupljen 
u kontrolnom selu koji bi istodobno sadržavao mjerljivu koncentraciju OTA i omjer Sa/So veći od jedan. 
Za razliku od uzoraka iz kontrolnog sela, četiri uzorka skupljena u Kaniži u 2000. godini i jedan uzorak u 
2005. godini upućivali su na istodobnu izloženost ovim mikotoksinima.
KLJUČNE RIJEČI: endemska nefropatija, fumonizin B
1
, okratoksin A, sfi ngolipidi
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